Boston Scientific Corp
BSX
View Detailed Chart
97.520USD
-0.220-0.23%
Close 12/05, 16:00（ET）Quotes delayed by 15 min
144.55BMarket Cap
51.79P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.23%
5 Days
-4.00%
1 Month
-2.50%
6 Months
-4.48%
Year to Date
+9.18%
1 Year
+8.27%
View Detailed Chart
TradingKey Stock Score of Boston Scientific Corp
Currency: USD Updated: 2025-12-05Key Insights
Boston Scientific Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 20/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 125.73.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Boston Scientific Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
36
analysts
Buy
Current Rating
125.732
Target Price
+28.93%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Boston Scientific Corp Highlights
StrengthsRisks
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 32.05% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 16.75B.
Undervalued
The company’s latest PE is 51.66, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 1.40B shares, increasing 0.04% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 21.57K shares of this stock.
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Boston Scientific Corp Info
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.
Ticker SymbolBSX
CompanyBoston Scientific Corp
CEOMr. Michael F. (Mike) Mahoney
Websitehttps://www.bostonscientific.com/en-US/Home.html
FAQs
What is the current price of Boston Scientific Corp (BSX)?
The current price of Boston Scientific Corp (BSX) is 97.520.
What is the symbol of Boston Scientific Corp?
The ticker symbol of Boston Scientific Corp is BSX.
What is the 52-week high of Boston Scientific Corp?
The 52-week high of Boston Scientific Corp is 109.500.
What is the 52-week low of Boston Scientific Corp?
The 52-week low of Boston Scientific Corp is 85.980.
What is the market capitalization of Boston Scientific Corp?
The market capitalization of Boston Scientific Corp is 144.55B.
What is the net income of Boston Scientific Corp?
The net income of Boston Scientific Corp is 1.85B.
Is Boston Scientific Corp (BSX) currently rated as Buy, Hold, or Sell?
According to analysts, Boston Scientific Corp (BSX) has an overall rating of Buy, with a price target of 125.732.
What is the Earnings Per Share (EPS TTM) of Boston Scientific Corp (BSX)?
The Earnings Per Share (EPS TTM) of Boston Scientific Corp (BSX) is 1.888.
Related Instruments
-0.85%
-0.30%
-0.44%
+1.18%
-0.41%
-0.15%
-0.62%
-0.19%
-1.46%
-0.31%
-1.14%
+0.58%
-0.47%
+0.05%
+0.47%
-1.94%
+2.20%
-0.13%
+3.56%Popular Symbols
